Welcome to another of our Eberhard F. Mammen award announcements. As noted previously, [1] [2] [3] Thieme, the publisher of Seminars in Thrombosis & Hemostasis, has created the "Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards" in honor of Eberhard F. Mammen, and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades. These awards began in 2009, under two categories; the current award details and conditions are as follows:
Most popular article awards: Awarded to the authors of the most popular articles published in Seminars in Thrombosis & Hemostasis. The awards are determined by the Editor in Chief on the basis of user statistics from Thieme e-Journals from the preceding 2 years. Prefaces, Errata, Letters to the Editor and Editorials, and previous award winners, are excluded from further consideration of these awards, which currently comprise two categories-one for "open access" articles, and another for a "General Category." There are two major cash prizes of US$1,000 for each category. In addition, winners of the "General Category" awards are granted "open access" status of these articles thereafter. Young investigator awards: Best presentation or meeting abstract by a young investigator-as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of US $1,000 are awarded in any year. There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other article related to the topic of their presentation (or as otherwise agreed) for publication in Seminars in Thrombosis & Hemostasis.
Further details of the awards and the award winners are posted online (available at: http://www.thieme. com/sth), and previous award winner announcements are also available in print. [4] [5] [6] [7] [8] [9] [10] [11] [12] The winners of the 2015 Eberhard F. Mammen awards for the most popular articles from Seminars in Thrombosis & Hemostasis for the period of 2012 to 2013 inclusive were announced in an earlier issue. 12 It is therefore with great pleasure that we would like to announce the winners of the 2015 Young Investigator awards related to meetings held in the recent past.
Young Investigator Awardees
As mentioned above, the Young Investigator awards represent winners of the best presentation or meeting abstract by a young investigator-as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. There are additional considerations given that the nominees' presentations are not always seen by all of the possible award nominators. The 2015 winners are identified below and also listed in ►Table 1. The six awardees were derived from a total of 16 nominees, seven from the DLSH 2015 meeting (18th International Meeting of the Danubian League Against Thrombosis and Haemorrhagic Disorders; May [14] [15] [16] 2015 ; Sarajevo) and 9 from the ISTH 2015 meeting (XXV Congress of the International Society on Thrombosis and Hemostasis; June 20-25, 2015; Toronto) . A meeting report from the DLSH meeting is available elsewhere in this issue of the journal. 13 Eberhard F. Mammen .
Dr. Juraj Sokol (►Fig. 1) is postdoctoral researcher at Jessenius Faculty of Medicine in Martin, Slovakia. He received his MD and PhD from Jessenius Faculty of Medicine in Martin, respectively, in 2010 and 2014. He is currently in a clinical training program for Hematology and Transfusion Medicine. In 2014, Dr. Sokol founded a civic organization "Young Haematologists" with several colleagues. The primary mis-sion of this organization is to give young hematologists in training the opportunity to present their scientific works at a national level. Dr. Sokol holds the most prestigious awards for young scientists in Slovakia (Guoth price from the Presidium of the Slovak Medical Association and Student Personality of Slovakia of the Year 2013 award in medical sciences and pharmacy). His research interests include: recurrent pregnancy loss, maternal thrombophilias, and thrombosis. He is author or coauthor of more than 120 professional and scientific publications.
Dr. Ljubica Jovanović (►Fig. 2) is a clinical doctor at the department of emergency cardiology at the Emergency Center, Clinical Center of Serbia, Belgrade. She graduated from the School of Medicine, University of Belgrade in 2011, and is currently undertaking PhD studies in Cardiology, as well as embarking on specialization in internal medicine, and is one of the youngest of our awardees. She has given several lectures in the field of hemostasis and cardiology at the national and regional-international congresses and is a member of several scientific societies. Dr. Jovanovic actively participates in several clinical trials, and has published several articles in peer-reviewed journals.
Dr. Lucia Stanciakova (►Fig. 3) received her medical degree from Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia in 2013, and so is the youngest of the Eberhard F. Mammen Young Investigator award winners. She has been working as a postgraduate student at the National Center of Hemostasis and Thrombosis, Clinic of Hematology and Transfusiology at the Martin University Hospital in Slovakia, with a special interest in the field of hemostasis and thrombosis. She is a member of the Slovak Society for Haemostasis and Thrombosis and in charge of the All award winners were thrilled to hear that they had been selected to receive an Eberhard F. Mammen Young Investigator award, and provided the following additional commentary:
It is with deepest appreciation that I express my thanks for being chosen as a recipient of the 2015 Eberhard F. Mammen Young Investigator award. To be nominated and then recognized with this award was an unexpected honor for which I am very grateful. However, I feel that this award recognizes not just my efforts, but also those of my colleagues. In particular, I wish to give a huge "thank you" to my supervisor Professor Peter Kubisz, for his unflagging support and ongoing advice.
-Juraj Sokol (►Fig. 1) I am very honored to have been selected for this prestigious award, being a young doctor interested in the challenging field of hemostasis and thrombosis. The main goal of my presentation was to provide a practical approach to the optimization and tailoring of antiplatelet therapy with the consideration of patient characteristics, with special concern of risk of bleeding and thrombosis. This award represents the recognition for the whole team of enthusiastic doctors in our Clinical Center of Serbia, Belgrade, and I hope we will be able to continue to contribute our ongoing research to improve health care.
It is an infinite honor and great pleasure for me to receive one of the 2015 Eberhard F. Mammen Young Investigator awards. I would like to sincerely thank my marvelous family, expert colleagues from the National Center of Hemostasis and Thrombosis in Slovakia and the editorial board of Seminars in Thrombosis & Hemostasis for this honor. I also thank all the people who continue to support my efforts to perform high-quality research and clinical studies, thus increasing our knowledge and helping our patients by improving their health care management. At our Slovak National Center of Hemostasis and Thrombosis I have the unique chance to participate in many projects, as we perform studies in various fields of thrombosis and hemostasis. Worldwide, the need for individualized thromboprophylaxis increases and studies focused on the extensive monitoring of hemostasis in pregnant women with thrombophilia are lacking. Therefore, with our research team we carefully follow-up the hemostatic parameters in this particular group of patients, who are at an increased risk of fetal loss and other pregnancy and thrombotic complications. Based on their results, we are immediately able to tailor their anticoagulant thromboprophylaxis. Finally, it is a great feeling for me to see the successful outcome-happy mother and healthy baby. In addition to such patient satisfaction and the positive effect of their treatment, this award provides me the motivation to continue in my enthusiasm into the future. I cordially hope to fulfill all future expectations.
-Lucia Stanciakova (►Fig. 3)
I am excited and honored to have received this award. My presentation was on the prevention of venous thromboembolism in adolescents and highlighted the need for further investigation into the efficacy and safety of mechanical and chemical thromboprophylaxis in this age group. I presented on behalf of a group of investigators from several large pediatric centers in the United Kingdom and I hope to continue to contribute to research in pediatric thrombosis and anticoagulation through the promotion of collaborative research within the United Kingdom and the wider research community.
It is a great honor to receive the Eberhard F. Mammen Young Investigator award. This award is both a prestigious and practical means to supporting our research on neutrophil extracellular traps with the goal of developing novel diagnostic strategies for thromboembolic and cardiovascular diseases. I would like to thank the members of my laboratory, collaborators, and mentors who made this award possible.
-Tobias Fuchs (►Fig. 5)
I was surprised and honored to learn that I had been granted one of the 2015 Eberhard F. Mammen awards. Our study on the association between anemia and cerebral venous thrombosis was a collaborative effort between the In keeping with last year's editorial, I decided to again review the Young Investigator awardees from previous years as well as the outcome of their subsequent submissions to Seminars in Thrombosis & Hemostasis, and as summarized in ►Table 2. I previously mentioned my personal gratification that most of the articles from earlier years have subsequently appeared in several annual top 100 listings. 9, 10 Of further interest, one of these articles actually won one of the Most Popular awards in 2014 (within the open access Category) and based on the "most popular" 2012 to 2013 list. 19 Also motivating is that a few of the Young Investigator awardees were also included as authors on other contributions to Seminars in Thrombosis & Hemostasis that were also listed in these most popular listings, including another 2014 Most Popular award winner. 37 These findings certainly appear to validate the Young Investigator award process, and I look forward to seeing their careers continue to develop. The above also suggests that future Young Investigator awardees have a very high bar to jump, given the precedence identified for the earlier awardees.
I would like as always to congratulate the current Young Investigator awardees for their awards, and will also take the opportunity to thank previous Young Investigator awardees Table 2 Young Investigator Awardees from previous years
Awardee
Year awarded for their contributions; these have obviously been well received by readers of this journal. I look forward to reading, and monitoring the future popularity, of the contributions from the latest group of Young Investigators!
